ClinicalTrials.gov
ClinicalTrials.gov Menu

Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01413737
Recruitment Status : Completed
First Posted : August 10, 2011
Last Update Posted : March 10, 2017
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
This is a retrospective, descriptive analysis of (1) 30 day postoperative results of surgery for lung cancer, (2) 30 day outcome predictors - compared to an earlier similar study in the same hospital (St Olav University Hospital, Trondheim, Norway).

Condition or disease
Lung Neoplasms

Study Type : Observational
Actual Enrollment : 148 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days
Actual Study Start Date : January 2002
Actual Primary Completion Date : December 2006
Actual Study Completion Date : December 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
lung cancer patients after surgery at St Olavs University Hospital
Criteria

Inclusion Criteria:

  • Lung cancer patients after surgery in 2002-2004 at dept for Heart and Lung Surgery, St.Olavs University Hospital, Trondheim, Norway.

Exclusion Criteria:

  • Carcinoid tumor, small-cell lung cancer, lung metastases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01413737


Locations
Norway
NTNU
Trondheim, Sør-Trøndelag, Norway, 7006
NTNU
Trondheim, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Study Chair: Rune Haaverstad, Ph.D NTNU

Publications of Results:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01413737     History of Changes
Other Study ID Numbers: 4.2005.1826
First Posted: August 10, 2011    Key Record Dates
Last Update Posted: March 10, 2017
Last Verified: March 2017

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases